1,4-Dioxane → HCID 23132499, compound
Reaction equation
Cl[C:2]1[C:11]2[C:6](=[CH:7][C:8]([O:14][CH3:15])=[C:9]([O:12][CH3:13])[CH:10]=2)[N:5]=[CH:4][N:3]=1.[NH2:16][C:17]1[S:18][C:19]2[CH:25]=[CH:24][C:23]([NH:26][C:27]([NH:29][C:30]3[CH:35]=[CH:34][C:33]([Cl:36])=[C:32]([C:37]([F:40])([F:39])[F:38])[CH:31]=3)=[O:28])=[CH:22][C:20]=2[N:21]=1.O1CCOCC1>CN(C)C=O>[Cl:36][C:33]1[CH:34]=[CH:35][C:30]([NH:29][C:27]([NH:26][C:23]2[CH:24]=[CH:25][C:19]3[S:18][C:17]([NH:16][C:2]4[C:11]5[C:6](=[CH:7][C:8]([O:14][CH3:15])=[C:9]([O:12][CH3:13])[CH:10]=5)[N:5]=[CH:4][N:3]=4)=[N:21][C:20]=3[CH:22]=2)=[O:28])=[CH:31][C:32]=1[C:37]([F:39])([F:38])[F:40]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
1-(4-Chloro-3-trifluoromethylphenyl)-3-[2-(6,7-dimethoxyquinazolin-4-ylamino)benzothiazol-5-yl]urea was prepared from 4-chloro-6,7-dimethoxyquinazoline (Fluorochem, 29 mg, 0.13 mmol) and 1-(2-aminobenzothiazol-5-yl)-3-(4-chloro-3-trifluoromethylphenyl)urea (Intermediate 5, 50 mg, 0.13 mmol) according to GP 1. Dimethylformamide was used as a solvent instead of dioxane. After removal of the solvent in vacuo, the residue was subjected to silica gel chromatography applying a dichloromethane-methanol gradient. The crude product was dissolved in dimethylformamide (2 mL) and water was added (2 mL). After storing in the fridge overnight, the resulting precipitate was filtered off, washed with water and dried (yellow solid, 7 mg, 12 μmol, 9%). LC/ESI-MS: m/z=575 [M(35Cl)+H]+; m/z=573 [M(35Cl)−H]−; Rt=4.17 min.
Workup
- customAfter removal of the solvent in vacuo
- dissolutionThe crude product was dissolved in dimethylformamide (2 mL)
- additionwater was added (2 mL)
- customAfter storing in the fridge overnight
- filtrationthe resulting precipitate was filtered off
- washwashed with water
- customdried (yellow solid, 7 mg, 12 μmol, 9%)
Sources & evidence
- ORD record
- ord-dcb4fc457ae04ec08ac9eabc846969f5
- Source dataset
- uspto-grants-2009_04
- Patent number
- US07514460B2
Reaction notes
Loading…